GWAS of BioBank Japan (BBJ) project

AH Asahi Hishida
MN Masahiro Nakatochi
YS Yoichi Sutoh
SN Shiori Nakano
YM Yukihide Momozawa
AN Akira Narita
KT Kozo Tanno
AS Atsushi Shimizu
AH Atsushi Hozawa
KK Kengo Kinoshita
TY Taiki Yamaji
AG Atsushi Goto
MN Mitsuhiko Noda
NS Norie Sawada
HI Hiroaki Ikezaki
MN Mako Nagayoshi
MH Megumi Hara
SS Sadao Suzuki
TK Teruhide Koyama
CK Chihaya Koriyama
SK Sakurako Katsuura-Kamano
AK Aya Kadota
KK Kiyonori Kuriki
MY Masayuki Yamamoto
MS Makoto Sasaki
ask Ask a question
Favorite

To increase the sample sizes, we obtained the GWAS summary statistics of the BBJ from the data repository of NBDC Human Database (https://humandbs.biosciencedbc.jp/hum0014-v26#58qt).12 The BBJ project is a large hospital-based case-control study launched in 2003 and collected DNA and clinical information from about 20,000 participants who visited about 130 hospitals throughout Japan,13 of whom 142,097 subjects had data for SCr and 143,658 subjects had data for eGFR after subjects with severe CKD (eGFR <15 mL/min/1.73 m2) were excluded from the analyses. The GWAS genotyping and imputation procedures are as described elsewhere.14

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A